Blood Pressure Drugs Linked to Lip Cancer

Report this content

A new study shows that long-term use of some common blood pressure drugs may be linked to an increased risk of lip cancer.

Researchers at Kaiser Permanente found that five anti-hypertensives with photosensitizing properties were linked to a 42 percent to 322 percent increased risk of lip cancer compared to a matched control group with no history of lip cancer, according to MedPage Today.

The five medications associated with the most significant risk included lisinopril, nifedipine, and atenolol as well as hydrochlorothiazide alone or in combination with triamterene.

The study, published in the Archives of Internal Medicine, found that the increased risk for lip cancer increased with duration for all the drugs except for atenolol, which was not linked to an increased cancer risk until five years of treatment.

Researchers noted that their study did not prove a cause and effect relationship but their analysis did show relatively high odds ratios, according to MedPage Today.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you. For legal help, call (800) 581-6358.

Tags: